ArticleJAMA network open2021

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy.

Edoardo Francini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.